Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.28 - $4.81 $621,356 - $911,196
189,438 Added 108.63%
363,820 $1.26 Million
Q4 2022

Feb 14, 2023

BUY
$3.65 - $4.82 $471,415 - $622,527
129,155 Added 285.57%
174,382 $781,000
Q3 2022

Nov 14, 2022

SELL
$2.66 - $3.97 $581,571 - $867,984
-218,636 Reduced 82.86%
45,227 $164,000
Q2 2022

Aug 15, 2022

BUY
$2.42 - $4.05 $246,682 - $412,836
101,935 Added 62.95%
263,863 $699,000
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $469,493 - $793,375
136,085 Added 526.58%
161,928 $634,000
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $126,372 - $196,148
25,843 New
25,843 $142,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.